Planta Med 2008; 74(8): 834-839
DOI: 10.1055/s-2008-1074555
Pharmacology
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Isoliquiritigenin Inhibits Cell Proliferation by a Heme Oxygenase-Dependent Pathway in Rat Hepatic Stellate Cells

Sun Wook Woo1 , Sung Hee Lee2 , Geonil Ko2 , Youn-Chul Kim2 , Dong Hwan Sohn2
  • 1National Institute of Toxicological Research, Korea Food and Drug Administration, Seoul, South Korea
  • 2Department of Pharmacy, Medicinal Resources Research Center, Wonkwang University, Iksan, Jeonbuk, South Korea
Weitere Informationen

Publikationsverlauf

Received: February 12, 2008 Revised: April 17, 2008

Accepted: May 4, 2008

Publikationsdatum:
18. Juni 2008 (online)

Preview

Abstract

We evaluated whether the antiproliferative effects of isoliquiritigenin (ISL) on rat hepatic stellate cells (HSCs) are related to the induction of heme oxygenase 1 (HO-1) expression. ISL significantly inhibited serum- or growth factor-induced HSC proliferation. The inhibition of platelet-derived growth factor (PDGF)-induced proliferation by ISL was associated with the mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt-p70S6K pathways. ISL induced the expression of HO-1 in HSCs. Using the chemical inhibitor tin protoporphyrin, we also found that the inhibitory action of ISL on PDGF-induced proliferation is mediated by HO-1. These data suggest that HO-1 expression is responsible for the antiproliferative effect of ISL on HSCs.

References

Dong Hwan Sohn

Department of Pharmacy

Wonkwang University

Iksan

Jeonbuk 570–749

South Korea

Telefon: +82-63-850-6822

Fax: +82-63-854-6038

eMail: dhsohn@wonkwang.ac.kr